Rare Diseases Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration
Boca Raton, FL, May 3, 2022 (GLOBE NEWSWIRE)— Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the“Company”), a development-stage biomedical company focused on novel treatments for rare diseases and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 3, 2022 Category: Pharmaceuticals Source Type: clinical trials

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
Conditions: Hereditary Spastic Paraplegia; Neurodegenerative Diseases; Pediatric Disorder; Spasticity, Muscle; Motor Neuron Disease; Movement Disorders Intervention: Sponsors: Boston Children's Hospital; Boston Children's Hospital - Children's Rare Disease Cohorts Initiative Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2022 Category: Research Source Type: clinical trials